stock.name

Intuitive Surgical Inc

ISRG

Market Cap$141.31B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Intuitive Surgical IncIntuitive Surgical Inc71.10%14%20.2-

Earnings Call Q4 2023

January 23, 2024 - AI Summary

Intuitive reported strong performance in Q4 2023, with procedure growth of 21% and revenue growth of 17% year-over-year.
The company submitted a 510(k) application for its next-generation multiport platform, da Vinci 5, to the FDA. The launch timing will depend on the resolution of FDA's questions.
Full-year procedure growth for 2023 was 22%, driven by strength in general surgery procedures in the US and diversification beyond urology in international markets.

Exclusive for Stockcircle Pro members

Sign upSign Up
$414.50

Target Price by Analysts

2.4% upsideIntuitive Surgical Target Price DetailsTarget Price
$99.31

Current Fair Value

75.5% downside

Overvalued by 75.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$141.31 Billion
Enterprise Value$136.51 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$5.54
Beta1.36
Outstanding Shares354,700,000
Avg 30 Day Volume1,047,630

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio71.1
PEG133.23
Price to Sales20.24
Price to Book Ratio10.38
Enterprise Value to Revenue18.65
Enterprise Value to EBIT73.84
Enterprise Value to Net Income68
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Intuitive Surgical Inc

CEO: Gary Guthart